NHINational Health Investors, Inc.

$64.85-14% 1Y

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 18.7 vs a 15.3 median over 41 quarters (+23% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What NHI's price assumes

National Health Investors, Inc. trades at 18.7× earnings against 38.1× for the median REIT - Healthcare Facilities name, cheaper than its own group.

18.7

Trailing P/E · REIT - Healthcare Facilities median 38.1 · cheaper than the typical name in its group

Price / sales
8.58

Price / sales · as of 2026-Q2

Price / book
2.36

Price / book · as of 2026-Q2

EV / sales
11.5

EV / sales

Details›
Price / bookas of 2026-Q2
2.36
EV / EBITas of 2026-Q2
35.6
EV / salesas of 2026-Q2
11.5
Real Estate median P/E130 names
25.0
REIT - Healthcare Facilities median P/E11 names
38.1
Market capitalisation
$3.70B
What the market has paid for these earnings: 41 quarters of its own multiple × $3.46 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$42.32
Its own P/E history, median$52.77
Its own P/E history, upper quartile$74.61
52-week range$63.98 – $90.00
Today$64.85

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.